Kairos Pharma Ltd. (KAPA) Stock Price

1.70 ▲ +0.09 (+5.59%)
Open: 1.66 Vol: 0 Day's range: 1.66 - 1.84 Sep 17, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KAPA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 1.72▼ 1.70▼ 1.71▼ 1.69▲ 1.54▲
MA10 1.71▼ 1.74▼ 1.69▲ 1.74▼ 1.28▲
MA20 1.74▼ 1.66▲ 1.66▲ 1.49▲ 0.95▲
MA50 1.68▲ 1.70▲ 1.76▼ 1.18▲ 1.16▲
MA100 1.68▲ 1.77▼ 1.59▲ 0.91▲ N/A    
MA200 1.77▼ 1.53▲ 1.33▲ 1.11▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.009▼ 0.006▲ 0.013▲ -0.007▼ 0.132▲
RSI 47.029▼ 50.989▲ 50.552▲ 62.591▲ 68.750▲
STOCH 45.033     36.795     64.211     47.589     66.152    
WILL %R -76.471▼ -43.750     -40.000     -45.055     -25.155    
CCI -66.667     9.051     52.706     41.201     124.919▲
Latest Filters Detected On KAPA
MA $KAPA Price Crossed Above MA(13) Set Alert
▲ GAP $KAPA Open Gap Up %3 Set Alert
▲ GAP $KAPA Open Gap Up %2 Set Alert
CDL $KAPA Shooting Star Candlestick Pattern Detected Set Alert
Kairos Pharma Ltd. News
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
Thursday, September 11, 2025 05:27 AM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it will host a premier KOL event on Thursday, Sept ...
Kairos Pharma Presents Phase 1 Data at Conference
Wednesday, September 03, 2025 08:54 AM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Kairos Pharma, Ltd. ( (KAPA)) has issued ...
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025
Wednesday, September 03, 2025 05:24 AM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation of initial Phase 1 data ...
KAPA historical stock data
date open high low close volume
17/09/25 1.66 1.84 1.66 1.70 1,299,887
16/09/25 1.60 1.63 1.48 1.61 885,371
15/09/25 1.73 1.76 1.58 1.58 1,134,329
12/09/25 1.82 1.82 1.67 1.76 820,700
11/09/25 1.85 1.86 1.50 1.80 2,051,300
10/09/25 1.95 2.099 1.83 1.85 1,100,700
09/09/25 1.75 1.98 1.72 1.97 1,448,500
08/09/25 1.78 2.11 1.73 1.85 3,784,700
05/09/25 1.58 1.73 1.58 1.72 2,148,628
04/09/25 1.41 1.57 1.401 1.55 1,308,796
Quote Details
52wk Low:0.40
52wk High:3.25
Vol:0
Avg Vol(3m):103.5M
1Y Chng:+25.00%
1M Chng:+74.75%
Add to Watch List
More Information
Index N/A
Market Cap. 32.78M